clinical 1,276 words KG: tDCS as Treatment for Motor Function in PSP (NCT07291687) 2026-03-27
kind:clinical-trialsection:clinical-trialsstate:published
Contents

tDCS as Treatment for Motor Function in PSP (NCT07291687)

Knowledge Graph

Related Hypotheses (7)

Restoring Neuroprotective Tryptophan Metabolism via Targeted
Score: 0.61
Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna
Score: 0.82
SASP-Mediated Cholinergic Synapse Disruption
Score: 0.76
Smartphone-Detected Motor Variability Correction
Score: 0.74
Sleep Spindle-Synaptic Plasticity Enhancement
Score: 0.72

Related Analyses (4)

4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · completed
Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived
Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · completed

Related Experiments (8)

4R-Tau Targeting Therapies for PSP and CBS
clinical · proposed · Score: 0.40
Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri
clinical · proposed · Score: 0.40
Brainstem Circuit Modulation for PSP
clinical · proposed · Score: 0.40
Levodopa Response Determinants in PSP — Biomarker-Guided Pre
clinical · proposed · Score: 0.40
Cytochrome Therapeutics
clinical · proposed · Score: 0.40

Knowledge Graph (1 edges)

tDCS as Treatment for Motor Function in PSP (NCT07291687) references BDNF

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)